Products for Research Use Only
RegisterLogin

PF-06688992

CAT: 0804-HY-P991668Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P991668Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
PF-06688992 is an antibody-drug conjugate (ADC) targeting the GD3 antigen, which is composed of humanized anti-GD3 huR24 linked to a chemotherapeutic agent. PF-06688992 can induce tumor cell apoptosis. PF-06688992 is promising for research of GD3-overexpressing tumors such as melanoma[1].
UNSPSC
12352100
Target
Antibody-Drug Conjugates (ADCs) ; Apoptosis
Related Pathways
Antibody-drug Conjugate/ADC Related; Apoptosis
Field of Research
Cancer
References & Citations
[1]Berois N, et al. Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives. Cancers (Basel) . 2022 Jan 27;14 (3) :645.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P991635PF-07329640
HY-P990645-01PF-03732010
HY-171821-01PF-08046054
HY-123803PF-06807656
HY-120195PF-04677490
HY-108338PF-05139962
HY-108327PF-05020182
HY-19530-01PF-2771
HY-10721-01PF-AKT400
HY-125415-01PF-4693627

Alternative Products

CatalogName
T9901A-1843-01PF-06688992
GTR18775387-01PF-06688992 Antibody
PTX25888Anti-Ganglioside GD3 (PF-06688992)
WA1122Research Grade Anti-Ganglioside GD3 (PF-06688992)
A136298Anti-Ganglioside GD3 (PF-06688992) Biosimilar (Monoclonal, IgG)
MBS579460PF-03084014 (PF-3084014)
BA5950-5.1PF-06928215
BA7028-5PF-4840154
B5563-10PF 5081090
BA8315-10PF-06747711

Popular Products